z-logo
open-access-imgOpen Access
PLXDC1 Can Be a Biomarker for Poor Prognosis and Immune Evasion in Gastric Cancer
Author(s) -
Xinwei Li,
Yongfei Fan,
Mingyue Tang,
Huiyuan Li,
Yue Zhang,
Jiaqi Mi,
Yanyan Wang,
Mengmeng Zhao,
Zishu Wang,
Fang Su
Publication year - 2022
Publication title -
journal of inflammation research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.656
H-Index - 33
ISSN - 1178-7031
DOI - 10.2147/jir.s383191
Subject(s) - immune system , immunohistochemistry , cancer , stromal cell , biology , cancer research , biomarker , tumor microenvironment , cd8 , immunology , oncology , medicine , biochemistry
Research has revealed that Plexin domain containing 1 (PLXDC1) is correlated with the prognosis of a variety of tumors, but its role in the tumor microenvironment (TME) of gastric cancer has not been reported.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here